[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371957-105":59,"doc-detail-371957-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","addressing-ancestral-underrepresentation-in-oncobiology-the-need-for-sub-saharan-african-specific-in-vitro-models","Addressing Ancestral Underrepresentation in Oncobiology - The Need for Sub-Saharan African-Specific In Vitro Models","","Cancer represents a rising public health burden in Sub-Saharan Africa (SSA), where cancer incidence is projected to increase by about 140% from 2022 to 2050. Meeting this need requires stronger epidemiological, clinical, and genetic/molecular characterization of SSA cancers and urgent improvement in genomic profiling of SSA tumour samples. Establishing suitable in vitro models is critical, since only ~6% of publicly available cancer cell lines reflect SSA ancestry. The paper argues for next-generation immortalization approaches, including conditional reprogramming, to create diverse, SSA patient-derived cell models while addressing practical challenges in low-to-middle-income settings, including Portuguese-speaking African countries.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/addressing-ancestral-underrepresentation-in-oncobiology-the-need-for-sub-saharan-african-specific-in-vitro-models/371957/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/addressing-ancestral-underrepresentation-in-oncobiology-the-need-for-sub-saharan-african-specific-in-vitro-models/371957.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is there an urgent need for SSA-specific in vitro models in oncobiology?","Question",{"text":112,"@type":113},"Cancer incidence in SSA is projected to rise substantially, and the region needs better epidemiological, clinical, and genetic/molecular characterization. Suitable in vitro models are needed to test hypotheses using representative SSA-derived systems.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the main limitation of publicly available cancer cell lines regarding SSA ancestry?",{"text":117,"@type":113},"Even with thousands of cancer cell lines created and deeply characterized, SSA ancestry is limited to about ~6% of publicly available lines. This reduces representativeness of African continental diversity.",{"name":119,"@type":110,"acceptedAnswer":120},"How do next-generation immortalization methods help address this gap?",{"text":121,"@type":113},"The article highlights approaches such as conditional reprogramming to establish cancer cell lines derived from SSA patients. This can better capture diversity across the African continent while enabling functional hypothesis testing.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371957,1790780099,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nAddressing Ancestral Underrepresentation in Oncobiology: The Need for Sub-Saharan African-Specific In Vitro Models  \nCarla S. dos Santos 1,2,3, Ana C. Magalhães 1,2, Ricardo J. Pinto 1,2,3, Carla Carrilho 4,5, Cláudia Pereira 6,7, Fernando Miguel 8, Pamela Borges 9, Lúcio Lara Santos 10,11 and Luisa Pereira 1,2, *  \nAcademic Editor: Hui Li  \nReceived: 27 October 2025  \nRevised: 17 November 2025  \nAccepted: 20 November 2025  \nPublished: 24 November 2025  \nCitation: dos Santos, C.S.; Magalhães, A.C.; Pinto, R.J.; Carrilho, C.; Pereira, C.; Miguel, F.; Borges, P.; Santos, L.L.; Pereira, L. Addressing Ancestral Underrepresentation in Oncobiology:  \nThe Need for Sub-Saharan AfricanSpecific In Vitro Models. Genes 2025, 16, 1403. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes16121403  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal  \n2 IPATIMUP—Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal  \n3 ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal  \n4 Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo 2HJP+QWV, Mozambique  \n5 Department o Pathology, Maputo Central Hospital, Maputo 2HJR+JFQ, Mozambique  \n6 Unidade Local de Saúde Almada-Seixal, 2805-267 Almada, Portugal  \n7 Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal  \n8 Angolan Institute Against Cancer, Luanda 56FG+7R6, Angola  \n9 Molecular Biology Laboratory, Hospital Universitário Agostinho Neto, Praia 112, Cape Verde  \n10 Grupo de Patologia e Terapêutica Experimental e Departamento de Oncologia do Instituto Português de Oncologia do Porto, 4200-072 Porto, Portugal  \n11 ONCOCIR—Education and Care in Oncology, PALOP—Lusophone Africa, 4200-072 Porto, Portugal  \n* Correspondence: [luisap@i3s.up.pt](luisap@i3s.up.pt)  \nAbstract  \nCancer is an increasing public health burden, including in Sub-Saharan African (SSA) populations, where cancer incidence is predicted to increase by around 140% between 2022 and 2050 . These rates require a better understanding of the epidemiological, clinical, and genetic/molecular characteristics of cancer in SSA populations. There is an urgent need to improve the genomic characterization of SSA tumour samples and also to establish suitable in vitro models for hypothesis testing. In fact, even though thousands of cancer cell lines (CCLs) have been established employing different methods of cell immortalization and have been included in deep molecular characterization panels, SSA ancestry is limited to only ~6%(mostly African Americans, who represent limited diversity in the context of the African continent) of publicly available CCLs. This disparity needs tobe addressed by using next-generation immortalization methods such as conditional reprogramming to establish CCLs derived from SSA cancer patients that also represent the diversity within the African continent. Research in SSA oncobiology has the potential to add essential information to better understand the diverse molecular pathways leading to cancer and to find promising therapeutic avenues. We also discuss the challenges to conducting oncobiology studies with cell modelling derived from SSA patients in low-to-middle-income African countries, such as Portuguese-speaking African countries.  \nKeywords: Sub-Saharan Africa; oncology research; in vitro models; cancer cell lines; conditional reprogramming  \n1. Introduction  \nSub-Saharan African (SSA) populations have had the deepest evolutionary history of our species si","cbCaishwkhA7Xhw5","https://ap.wps.com/l/cbCaishwkhA7Xhw5","pdf",1695636,25,"English","# Abstract\n# Introduction\n## Evolutionary history and genetic diversity in SSA\n## Cancer burden and projected mortality\n## Underrepresentation in genomics and disease cohorts\n## Implications for oncobiology and therapeutic discovery\n## Current progress and the gap in representative cell models","[{\"question\":\"Why is there an urgent need for SSA-specific in vitro models in oncobiology?\",\"answer\":\"Cancer incidence in SSA is projected to rise substantially, and the region needs better epidemiological, clinical, and genetic/molecular characterization. Suitable in vitro models are needed to test hypotheses using representative SSA-derived systems.\"},{\"question\":\"What is the main limitation of publicly available cancer cell lines regarding SSA ancestry?\",\"answer\":\"Even with thousands of cancer cell lines created and deeply characterized, SSA ancestry is limited to about ~6% of publicly available lines. This reduces representativeness of African continental diversity.\"},{\"question\":\"How do next-generation immortalization methods help address this gap?\",\"answer\":\"The article highlights approaches such as conditional reprogramming to establish cancer cell lines derived from SSA patients. This can better capture diversity across the African continent while enabling functional hypothesis testing.\"}]","Addressing Ancestral Underrepresentation in Oncobiology - The Need for Sub-Saharan African-Specific In Vitro Models | PDF",1790193322,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f32d3205e4aebdcddfad2c3e74ced011.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f975b5d2553a7e3b8ead9a006b4de9b1.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/019815611ad68e9bb98078191a50a639.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07ea1b174300078789cb86e205dc3402.webp",980,1385]